Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 109.00%133.42K | 83.65%-380.76K | 101.01%11.18K | 31.76%-5.71M | 24.20%-794.47K | -4.41%-1.48M | 46.81%-2.33M | 27.41%-1.1M | -17.26%-8.37M | 74.21%-1.05M |
| Net income from continuing operations | -67.15%645.48K | -95.66%53.42K | -9.19%-934.46K | 68.83%-1.93M | 49.41%-4.27M | 75.21%1.96M | 95.69%1.23M | -271.34%-855.83K | -201.20%-6.18M | -401.51%-8.43M |
| Operating gains losses | 60.67%-1.45M | 44.87%-1.2M | 158.09%740.19K | 47.77%-5.45M | -40.87%1.7M | -0.57%-3.69M | 57.13%-2.18M | 71.92%-1.27M | 54.07%-10.43M | 135.05%2.87M |
| Asset impairment expenditure | ---- | ---- | ---- | --38.07K | ---- | ---- | ---- | ---- | --0 | ---- |
| Unrealized gains and losses of investment securities | --0 | --0 | --0 | -532.69%-46.72K | --0 | -4,036.95%-54.86K | 121.38%7.37K | -93.37%758 | -108.07%-7.39K | 436.20%17K |
| Remuneration paid in stock | 2,244.27%56.72K | 105.75%35.92K | -72.52%42.73K | -118.75%-498.21K | -104.81%-26.46K | -100.38%-2.65K | -189.69%-624.6K | -78.06%155.49K | 12.79%2.66M | -60.44%549.95K |
| Deferred tax | --408.94K | --327.29K | ---253.88K | -65.27%973.18K | --973.18K | --0 | --0 | --0 | -43.63%2.8M | ---- |
| Other non cashItems | -7.71%451.19K | 964.74%476.97K | -17.43%471.21K | -44.84%1.49M | -22.97%485.04K | -21.65%488.88K | -107.58%-55.16K | -20.60%570.71K | -28.23%2.7M | -33.71%629.64K |
| Change In working capital | 110.84%20.85K | 90.04%-69.88K | -118.26%-54.61K | -424.94%-292.28K | -40.96%302.24K | 4.36%-192.27K | 46.07%-701.37K | -72.29%299.13K | 105.20%89.95K | 134.24%511.94K |
| -Change in receivables | 516.16%72.19K | 44.75%-59.45K | 468.85%296.07K | -371.50%-220.14K | -106.74%-14.91K | -116.75%-17.35K | 49.11%-107.61K | 49.84%-80.27K | 97.33%-46.69K | 118.26%221.21K |
| -Change in payables and accrued expense | 70.65%-51.34K | 98.24%-10.43K | -192.43%-350.69K | -152.79%-72.14K | 9.09%317.15K | 42.58%-174.93K | 45.48%-593.76K | -69.39%379.39K | 641.19%136.64K | 202.61%290.73K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 109.00%133.42K | 83.65%-380.76K | 101.01%11.18K | 31.76%-5.71M | 24.20%-794.47K | -4.41%-1.48M | 46.81%-2.33M | 27.41%-1.1M | -17.26%-8.37M | 74.21%-1.05M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -66.22%1.37M | 0 | -60.95%1.16M | -51.67%7.01M | 0 | -15.29%4.05M | 0 | -69.55%2.96M | 109.46%14.51M | 0 |
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net business purchase and sale | -66.10%1.37M | --0 | -60.95%1.16M | -51.78%7M | --0 | -15.59%4.04M | --0 | -69.55%2.96M | 109.34%14.51M | --0 |
| Net investment purchase and sale | ---- | ---- | ---- | --14.59K | --0 | ---- | ---- | ---- | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -66.22%1.37M | --0 | -60.95%1.16M | -51.67%7.01M | --0 | -15.29%4.05M | --0 | -69.55%2.96M | 109.46%14.51M | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 93.36%-37.52K | -2,113.53%-196.45K | -7,002.38%-630.34K | -59.00%-1.08M | 46.32%-495.73K | -6,264.17%-564.82K | -103.59%-8.88K | -224.74%-8.88K | 51.04%-678.2K | -48.73%-923.53K |
| Net issuance payments of debt | -13.61%-10.08K | 0.00%-8.88K | 0.00%-8.88K | 0.00%-35.5K | 0.00%-8.88K | 0.00%-8.88K | 0.00%-8.88K | 0.00%-8.88K | 11.93%-35.5K | 49.91%-8.88K |
| Net common stock issuance | 95.06%-27.44K | ---187.58K | ---621.46K | -483.45%-1.04M | ---486.85K | ---555.95K | --0 | --0 | 136.67%271.95K | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -63.30%-818.97K | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5.93%-95.68K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 93.36%-37.52K | -2,113.53%-196.45K | -7,002.38%-630.34K | -59.00%-1.08M | 46.32%-495.73K | -6,264.17%-564.82K | -103.59%-8.88K | -224.74%-8.88K | 51.04%-678.2K | -48.73%-923.53K |
| Net cash flow | ||||||||||
| Beginning cash position | 9.16%8.02M | -11.23%8.6M | 2.86%8.06M | 230.77%7.83M | -4.66%9.35M | 13.82%7.35M | -8.52%9.68M | 230.77%7.83M | -40.22%2.37M | 177.27%9.81M |
| Current changes in cash | -26.91%1.46M | 75.31%-577.21K | -70.92%537.79K | -95.90%224.14K | 34.56%-1.29M | -40.25%2M | 43.41%-2.34M | -77.49%1.85M | 443.01%5.47M | -68.80%-1.97M |
| End cash Position | 1.44%9.48M | 9.16%8.02M | -11.23%8.6M | 2.86%8.06M | 2.86%8.06M | -4.66%9.35M | 13.82%7.35M | -8.52%9.68M | 230.77%7.83M | 230.77%7.83M |
| Free cash from | 109.00%133.42K | 83.65%-380.76K | 101.01%11.18K | 31.76%-5.71M | 24.20%-794.47K | -4.41%-1.48M | 46.81%-2.33M | 27.41%-1.1M | -17.19%-8.37M | 73.90%-1.05M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.